Telemedicine is Superior to Onboard Neurologists for Optimizing Mobile Stroke Unit Efficiency: Results from the MSU-TELEMED Trial
Highlights
- The MSU-TELEMED trial found that a telemedicine-based care model for Mobile Stroke Units (MSUs) is superior to the traditional onboard neurologist model based on a composite outcome of safety, speed, and resource efficiency.
- Telemedicine achieved a win-odds ratio of 3.5 (95% CI, 2.4-5.1), driven primarily by a 67-percentage-point increase in the neurologist’s time spent in direct patient care.
- While telemedicine resulted in a median 4-minute delay in scene-to-treatment-decision time (19 minutes vs. 13 minutes), safety profiles and adverse event rates remained comparable between both models.
Background: The Evolution of Prehospital Stroke Care
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.